130 related articles for article (PubMed ID: 38336373)
1. Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study.
Nguyen NTT; Diaz N; Reid H; Previs R; Havrilesky LJ; Secord AA; Berchuck A
Int J Gynecol Cancer; 2024 Apr; 34(4):528-534. PubMed ID: 38336373
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers.
Tamura R; Kitani Y; Takahashi K; Yamaguchi M; Nishikawa N; Kawasaki T; Kikuchi A
J Obstet Gynaecol; 2023 Dec; 43(2):2283162. PubMed ID: 37983014
[TBL] [Abstract][Full Text] [Related]
3. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
4. Synchronous Primary Endometrial and Ovarian Cancers: Trends and Outcomes of the Rare Disease at a South Asian Tertiary Care Cancer Center.
Khalid N; Ullah F; Zafar H; Anwer AW; Abbas T; Shakeel O; Faisal M; Sadaf T; Syed AA
Cureus; 2020 Jul; 12(7):e9163. PubMed ID: 32802600
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
6. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study.
Lim YK; Padma R; Foo L; Chia YN; Yam P; Chia J; Khoo-Tan H; Yap SP; Yeo R
J Gynecol Oncol; 2011 Dec; 22(4):239-43. PubMed ID: 22247800
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases.
Liu Y; Li J; Jin H; Lu Y; Lu X
Oncol Lett; 2013 Jan; 5(1):267-270. PubMed ID: 23255933
[TBL] [Abstract][Full Text] [Related]
9. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
10. Impact of abnormal uterine bleeding care in premenopausal patients prior to endometrial malignancy diagnosis.
Grubman J; Mora V; Nguyen M; Ladwig N; Chen LM; Jacoby V
Gynecol Oncol Rep; 2023 Dec; 50():101292. PubMed ID: 37868015
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
12. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
13. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care and outcomes for endometrial and ovarian cancers in botswana 2015-2021.
Lumley C; Batman S; Bazzett-Matabele L; Monare B; Bvochora-Nsingo M; Chiyapo S; Ketlametswe R; Mbulawa G; Seiphetlheng A; Ramontshonyane G; Ralefala T; Luckett R; Vuylsteke P; Grover S
Gynecol Oncol Rep; 2023 Oct; 49():101262. PubMed ID: 37691756
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
Lim H; Bang SH; Kim Y; Cho SH; Shin W; Kim SI; Kim TH; Suh DH; Lim MC; Kim JW
BMC Cancer; 2022 Jun; 22(1):703. PubMed ID: 35761211
[TBL] [Abstract][Full Text] [Related]
18. Prediction of histologic type and lymph node metastasis for advanced ovarian cancer on uterine cervical and endometrial cytology.
Suzuki M; Suzuki T; Matsuura M; Iwasaki M; Tanaka R; Ito E; Fujii M; Saito T
Acta Cytol; 2010; 54(4):575-81. PubMed ID: 20715659
[TBL] [Abstract][Full Text] [Related]
19. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
